Immunomodulators — Tablets That Work on the Immune System

Immunomodulators are cancer medicines taken by mouth that change how the immune system behaves around a tumour, instead of attacking tumour cells directly. They are small molecules, so they can be swallowed rather than infused. In cancer care the word usually points to one family in particular: the immunomodulatory imide drugs, shortened to IMiDs, used mostly in blood cancers.

That is the part patients find hardest to place. A drip looks like cancer treatment. A capsule taken with breakfast at home does not. Yet the capsule is doing something the drip does not do: it works from inside the cell, on the machinery that decides which proteins survive and which are thrown away.

The mechanism is described in NCCN and ESMO patient-education material in roughly these strands. Only class and mechanism terms are used on this page — no product is named, and no product is compared with another.

• It binds a protein called cereblon — cereblon is part of the cell’s protein-disposal system. The medicine changes which proteins that system tags for destruction.
• Some cancer-survival proteins are removed — in myeloma cells, two proteins the cancer depends on to keep growing are among those degraded once the medicine is bound.
• Immune cells are switched back on — T cells and natural killer cells nearby become more active and release more signalling chemicals.
• The environment around the cancer changes — the medicine reduces the supportive signals that bone-marrow tissue gives a myeloma cell, so the cancer sits in less friendly ground.
• New blood-vessel growth is dampened — the class also reduces the formation of the new vessels that a growing tumour needs.

The word immunomodulator is sometimes used more loosely, for injected immune-signalling proteins or for supplements sold with immune claims. Those are different things. The injected signalling proteins have their own history and their own place today, covered on cytokine therapy: interferon, interleukin and where they stand now. Nothing sold over the counter as an immunity booster belongs in this category.

Everything on this page is class-level explanation from a scientific standpoint. It is not a recommendation to use any medicine, and it is not a substitute for your own haematologist or medical oncologist reviewing your reports.

The last two rows are the ones families underestimate. A capsule feels less serious than a drip, so it is easier to skip a dose, easier to keep taking it through a symptom that should have been reported, and easier to run out because a refill was not planned. The medicine is not gentler. Only the delivery is.

This table sets out how two classes are given and watched. It is not a comparison of how well they work, and no such comparison is offered here.

It is not for everyone with these diagnoses. Pregnancy, or the possibility of pregnancy without the required precautions, rules the class out. So can very low blood counts, an unexplained recent clot before a prevention plan is in place, significant kidney impairment without a dose adjustment, and existing nerve damage in the hands and feet. Whether a given agent in this class is approved and marketed in India is a CDSCO matter and changes over time — ask your treating team what is actually available rather than assuming from an overseas source.

Settings above follow the disease categories used in current NCCN and ESMO guidance as applied in Indian practice, as of August 2026. This is orientation, not an allocation to any treatment.

One reassurance is worth stating plainly. The immune-attack reactions that dominate conversation about infused immunotherapy — inflamed bowel, inflamed lungs, an inflamed thyroid or an inflamed heart muscle — are not the usual pattern with this oral class. That does not make it a mild medicine. It means the things to watch are different ones.

1. 1

   Before the first capsule

   Baseline blood counts, kidney function and a clot-risk assessment are done first. Pregnancy status is established where it applies. Your team also asks what else you take, including supplements and traditional medicines — that question is asked to keep you safe, not to judge what you use.

2. 2

   The cycle

   Most regimens run on a 28-day cycle with dosing on most days and a planned gap. Take it at the same time daily. Swallow the capsule whole — it is not opened, split or crushed. If you miss a dose, ask your team what to do rather than doubling up.

3. 3

   Clot prevention runs alongside

   A blood thinner is chosen for your level of risk and started with the treatment. It is part of the prescription, not an optional extra, and the risk is higher when a steroid is in the regimen. Never stop it on your own, and tell your team before any procedure or dental work.

4. 4

   Blood tests between cycles

   Counts are the steering wheel for this class. They decide whether the next cycle starts on time, at the same dose, or at a reduced one. A dose reduction is a normal adjustment made to keep you on treatment, not a sign that anything has failed.

5. 5

   The pregnancy-prevention rules

   This class causes severe birth defects, so it is dispensed under a controlled programme. Documented pregnancy testing and reliable contraception are required where pregnancy is possible. Men use barrier contraception too, because the medicine is present in semen. Blood and sperm donation are not permitted during treatment or for a period afterwards.

6. 6

   Storage, sharing and telling other doctors

   Keep capsules in the original blister, out of reach of children, and return unused stock to the pharmacy. Never pass them to a relative with a similar diagnosis. Tell every other doctor and dentist you see that you are on this class — it changes what they prescribe and how they plan a procedure.

It arrives as a monthly pharmacy bill rather than a per-cycle hospital bill, and it keeps arriving. That single difference matters more than the sticker price. A course of infusions has a countable number of cycles. Maintenance with a capsule can continue for months or years, so the running total behaves differently even when the monthly figure looks modest.

Three things shape what a family actually pays in India, and all three should be checked before treatment starts rather than after.

• Older agents in the class are made in India — generic manufacture has brought the cost of the longest-established members of this class well below that of imported infused biologics. Newer members of the class have not followed yet. Any figure quoted to you is indicative only, as of August 2026.
• Insurance treats home medicines differently — many Indian policies pay readily for day-care infusion because it is a hospital procedure, then treat medicines taken at home as outpatient or domiciliary cover, which is often capped or excluded. Read that clause, in writing, before the first prescription.
• Government schemes have their own lists and ceilings — Aarogyasri and comparable schemes cover defined packages with defined limits, and oral medicines are handled differently from procedures. Ask the hospital scheme desk to confirm in writing what is covered for your specific plan.

Ask for a written monthly estimate that includes the medicine, the blood tests between cycles, the clot-prevention prescription and the supportive medicines. A figure for the capsule alone will understate what the month costs. At CION, cost is discussed before treatment starts, in writing, and the estimate names what is included and what is not.

No price for any specific medicine is given on this page. Costs vary by centre, by supplier and over time, and every figure discussed with you is indicative only, as of August 2026.

• Antibody-Drug Conjugates: Immunotherapy or Chemotherapy? — the other class whose name causes constant confusion, and a straight answer on where it really sits.
• Cytokine Therapy: Interferon, Interleukin and Where They Stand Now — the injected immune-signalling proteins that the word immunomodulator is sometimes stretched to cover.
• Oncolytic Virus Therapy: Using a Virus to Attack Cancer — a different route again, and a useful contrast to a medicine you simply swallow.
• Immunotherapy at CION Cancer Clinics — the hub page: biomarker testing, day-care administration, monitoring and support in one place.

This page explains a class of medicine from a scientific standpoint. It is general information, not a treatment recommendation, and not a substitute for consultation with your own haematologist or oncologist. No molecule or brand is named or endorsed here, and no comparison of one product against another is made. Immunotherapy is administered as day care at CION centres; response-assessment PET-CT is coordinated at partner imaging centres. CION does not provide CAR-T or cell therapy. Any cost mentioned is indicative only, as of August 2026. Only your treating team, reviewing your complete case, can say whether any of this applies to you.

Asking what a tablet does is not doubting your doctor

Wanting to know what is going into your body before you agree to take it is good sense. Our team takes the time to explain the mechanism, the schedule and the honest limits.